Alvotech Stock (NASDAQ:ALVO), Trade Ideas

Alvotech

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.

Fifth Third Bancorp - logo

News

Intraday Update

Markets

Movers

ALVO

FITB

HUMA

MNDR

NUVB

PARA

TELL

Fifth Third Bancorp Reports Upbeat Earnings, Joins Metropolitan Bank Holding, Paramount Global And Other Big Stocks Moving Higher On Friday

Penny Stocks

Small Cap

Trading Ideas

AEHR

CHWY

CRML

IVVD

LPRO

RGEN

SERA

TRAK

VMEO

U.S. stocks were lower, with the Dow Jones index falling around 100 points on Monday.

Aehr Test Systems Reports Preliminary Results, Joins Dyne Therapeutics, United Airlines And Other Big Stocks Moving Lower On Monday

Viersen,,Germany,-,May,9.,2020:,Close,Up,Of,Mobile

Large Cap

Health Care

General

ABBV

TEVA

FDA-approved Simlandi (adalimumab-ryvk): a high-concentration biosimilar to Humira for rheumatoid arthritis, psoriasis, and more.

Why Is Generic Drugs Player Teva Pharma Stock Trading Higher Today?

ALVOPETRO ENEGY LTD by Alvopetro Energy Ltd

Alvopetro Energy Ltd

Wedbush analyst David Chiaverini maintains Customers Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CUBI#NYSE">CUBI</a>) with a Outperform and lowers the price target from $63 to $61.

Price Target

Analyst Ratings

CUBI

Wedbush Maintains Outperform on Customers Bancorp, Lowers Price Target to $61

Barclays analyst Benjamin Budish maintains Nasdaq (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDAQ#NASDAQ">NDAQ</a>) with a Overweight and lowers the price target from $76 to $73.

NDAQ

Barclays Maintains Overweight on Nasdaq, Lowers Price Target to $73

Piper Sandler analyst Scott Siefers maintains Comerica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>) with a Neutral and raises the price target from $54 to $56.

Piper Sandler Maintains Neutral on Comerica, Raises Price Target to $56

Piper Sandler analyst Scott Siefers upgrades Citizens Financial Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CFG#NYSE">CFG</a>) from Neutral to Overweight and raises the price target from $35 to $41.

Upgrades

Piper Sandler Upgrades Citizens Financial Group to Overweight, Raises Price Target to $41

WIIM

KLAC

KLA Corporation shares are trading higher after the company reported better-than-expected Q3 financial results and issued guidance.

Ginkgo Bioworks Holdings's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DNA#NYSE">DNA</a>) short percent of float has risen 3.26% since its last report. The company recently reported that it has 270.83 million shares sold short, which is 19.94% of all regular shares that are available for trading. Based on its trading volume, it would take traders 16.88 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Ginkgo Bioworks Holdings Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714140922_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Ginkgo Bioworks Holdings has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Ginkgo Bioworks Holdings's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Ginkgo Bioworks Holdings's peer group average for short interest as a percentage of float is 3.35%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Looking Into Ginkgo Bioworks Holdings's Recent Short Interest

D.R. Horton's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHI#NYSE">DHI</a>) short percent of float has risen 6.78% since its last report. The company recently reported that it has 4.99 million shares sold short, which is 1.89% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.62 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>D.R. Horton Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714140917_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for D.R. Horton has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing D.R. Horton's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, D.R. Horton's peer group average for short interest as a percentage of float is 6.25%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Peering Into D.R. Horton's Recent Short Interest

Amphenol's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APH#NYSE">APH</a>) short percent of float has risen 5.84% since its last report. The company recently reported that it has 7.60 million shares sold short, which is 1.45% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.37 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Amphenol Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714140912_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Amphenol has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Amphenol's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Amphenol's peer group average for short interest as a percentage of float is 4.25%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into Amphenol's Recent Short Interest

Susquehanna analyst Bascome Majors maintains Union Pacific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNP#NYSE">UNP</a>) with a Neutral and raises the price target from $255 to $270.

Susquehanna Maintains Neutral on Union Pacific, Raises Price Target to $270

Barclays analyst Stephanie Davis maintains Laboratory Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LH#NYSE">LH</a>) with a Equal-Weight and lowers the price target from $234 to $213.

Laboratory Corporation Of America Holdings

Barclays Maintains Equal-Weight on Laboratory Corp, Lowers Price Target to $213

Wedbush analyst David Chiaverini reiterates Cullen/Frost Bankers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CFR#NYSE">CFR</a>) with a Neutral and maintains $115 price target.

Reiteration

Wedbush Reiterates Neutral on Cullen/Frost Bankers, Maintains $115 Price Target

Susquehanna analyst Charles Minervino maintains Textron (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TXT#NYSE">TXT</a>) with a Positive and lowers the price target from $110 to $105.

Susquehanna Maintains Positive on Textron, Lowers Price Target to $105

Former President Donald Trump was ordered to pay <a href="https://www.benzinga.com/news/24/02/37382129/trumps-appeal-against-450m-judgment-collection-rejected-by-ny-judge-former-presidents-properties-at">$355 million in penalties</a> for fraud charges and profits on the sale of different assets.&nbsp;
The penalties have been accumulating interest at a rate of 9% per year and have snowballed to current liabilities above $450 million. The fine is growing at a rate of <a href="https://www.benzinga.com/news/24/02/37235445/donald-trumps-unpaid-355m-fine-accumulates-2-6m-in-interest-every-month-judge-rules">$2.6 million per month</a>. The penalties have put Trump at risk of the court seizing his assets.&nbsp;
With a costly presidential campaign and high levels of financial scrutiny, Trump's ability to repay the fine is questionable, and many wonder whether he will be able to pay it back at all.&nbsp;
Don't Miss:
<ul>
<li>If you invested $100 in DOGE when Elon Musk first tweeted about it in 2019,<a href="https://www.benzinga.com/money/etoro-doge"> here&#8217;s how much you&#8217;d have today</a>.</li>
<li>Bitcoin has jumped another 45% already this year &#8211;<a href="https://www.benzinga.com/money/kraken"> how much would you need to get started today?</a></li>
</ul>
But Trump's crypto holdings are not often considered in this ordeal. While the holdings are just a drop in the bucket compared to the amount owed, the potential price appreciation could help Trump pay the penalties.
Trump's crypto portfolio was discovered by Arkham Intelligence, which cross-referenced Trump's financial disclosures with transactions on the blockchain to find his <a href="https://platform.arkhamintelligence.com/explorer/entity/donald-trump">wallet address</a>.&nbsp;
The wallet holds several million dollars in cryptocurrency, most of which is between three different tokens: Ethereum (ETH) Wrapped Ethereum (WETH) and MAGA Coin (TRUMP).
The ETH and WETH were obtained through the Trump Digital Trading Cards non-fungible token (NFT) project. Though Trump was not affiliated with the project, the creators gave him royalties exceeding 1,700 ETH. In December, <a href="https://www.benzinga.com/markets/cryptocurrency/24/02/37185916/donald-trump-sold-2-4-million-in-eth-last-month-missed-out-on-500-000-in-potential-profit">Trump sold 1,075 of these ETH tokens</a>, which generated proceeds of $2.4 million.&nbsp;
<hr class="wp-block-separator has-alpha-channel-opacity" />
Trending: Large boom in cryptocurrency and metaverse interest as BTC skyrockets —<a href="https://www.benzinga.com/money/ceek"> has Apple Vision Pro increased the demand for virtual real estate?</a>
<hr class="wp-block-separator has-alpha-channel-opacity" />
Regarding potential growth, the roughly 700 ETH Trump has remaining could be worth as much as $7 million by the end of 2025, based on a <a href="https://www.benzinga.com/money/ethereum-eth-price-predictions">price prediction</a> of $10,000. Trump could also continue to receive cash from NFT projects and royalties in the future.
While ETH could see growth in the coming months and years, Trump could generate much more profit from MAGA Coin (TRUMP). The creators of this token sent Trump 580,000 tokens when the project launched in August. At the time, the tokens were worth a few thousand dollars, but they have since appreciated to over $3 million.&nbsp;
The token could continue to grow if Trump wins the election in November or if he directly endorses the project. Other meme coins, such as dogwifhat (WIF) and Bonk (BONK) have attracted investment to the order of several billion dollars. So, if MAGA Coin were to reach a market cap of $3 billion, similar to WIF, the price would be around $70, and Trump's position would be worth over $40 million.&nbsp;
This is unlikely to happen, as a $3 billion market cap is far from the current level of around $250 million, and numerous events would have to play out for the token to get there.&nbsp;
With that in mind, Trump's crypto dealings have a small chance of providing relief to his financial situation. Because the portfolio is public, anyone can monitor his positions and how much he has in crypto.&nbsp;
Read Next:
<ul>
<li>About 22% of the adult population in the U.S. own a share of Bitcoin,<a href="https://www.benzinga.com/money/kraken"> how much would $10 get you today</a>?</li>
<li>The<a href="https://www.benzinga.com/money/kraken-2"> last-standing top crypto exchange without a major security breach</a> offers what now?</li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Donald Trump's Crypto Investments Could Help Pay Back His $450M In Damages

Susquehanna analyst Mehdi Hosseini maintains Teradyne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>) with a Positive and raises the price target from $125 to $130.

Susquehanna Maintains Positive on Teradyne, Raises Price Target to $130

Barclays analyst Tim Long maintains Juniper Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNPR#NYSE">JNPR</a>) with a Equal-Weight and raises the price target from $40 to $41.

JNPR

Barclays Maintains Equal-Weight on Juniper Networks, Raises Price Target to $41

In a recent prediction, Strike CEO Jack Mallers has forecasted a potential seven-figure price for Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) during the current cycle, driven by efforts to save the bond market.
What Happened: Mallers, the head of Bitcoin&#8217;s Lightning Network wallet Strike, believes that Bitcoin could appreciate between 297% and 1,486% from its current level, Daily Hodl <a href="https://dailyhodl.com/2024/04/26/violent-to-the-upside-this-catalyst-could-see-bitcoin-explode-by-up-to-1486-says-strike-ceo-jack-mallers/">reported</a> on Friday. This prediction is based on the potential loosening of monetary policy in an attempt to save the bond market.
Mallers pointed out that the bond market is facing significant challenges for arguably the first time in modern financial history. He noted that bondholders, including banks, are suffering as the bonds purchased with their deposits are underwater.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38386424/shiba-inu-whale-accumulates-237b-shib-in-one-transaction-much-in-store-for-the-shib-army-v?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Shiba Inu Whale Accumulates 237B SHIB In One Transaction: &#8216;Much In Store For The SHIB Army,&#8217; Vows Lead Developer</a>
Mallers suggests that if central banks and governments attempt to salvage the bond market, the required liquidity will send asset prices soaring. 
He stated, &#8220;So if that happens it&#8217;s impossible to speculate on an asset as scarce as Bitcoin. But I think $250,000 to one million is the imagination I have in that range of just how big this can get.&#8221;
He further emphasized that the price of Bitcoin is the &#8220;most accurate key performance indicator (KPI)&#8221; for its adoption. Mallers expects more global adoption of Bitcoin as a monetary unit, which he believes will drive its value &#8220;violent to the upside&#8221; against the dollar and other fiat currencies.
Why It Matters: Earlier, a significant technical indicator had<a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38450026/bitcoin-sell-signal-on-12-hour-chart-sparks-concerns-analyst-warns-exercise-caution-given-"> prompted a sell-off signal for Bitcoin</a>, raising concerns among traders and investors. The digital currency was also encountering resistance at the mid-level of a parallel channel.
However, cryptocurrency influencer and analyst Lark Davis also shared a<a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38407752/bitcoin-veteran-warns-crypto-bears-you-have-no-idea-how-crazy-this-bull-run-is-about-to-be"> bullish outlook on the Bitcoin </a>market, indicating that the bull run was far from over. He cited several key factors, including a 6.4% surge in large transaction volume to $47.1 billion.
Price Action: According to <a href="https://pro.benzinga.com">Benzinga Pro</a>, Bitcoin was trading at 0.68% lower at $63,855.60.
Read Next: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38441839/crypto-trader-describes-his-technique-to-spot-altcoins-before-a-100x-surge?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Crypto Trader Describes His Technique To &#8216;Spot Altcoins Before A 100X Surge&#8217;</a>
Image via Shutterstock
<div style="font-family: 'Lato', sans-serif">
<div>
<hr style="border: 0;height: 5px;background: #225aa9" />
<div style="background-color: #f5f5f5;background-position: center;background-size: cover;justify-content: center"></div>

 Engineered by Benzinga Neuro, Edited by 
 <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Pooja Rajkumari</a> 
 
 
<hr style="border: 0;height: 1px;background: #225aa9" />

 The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. 
 <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Learn more.</a>
 
<hr style="border: 0;height: 5px;background: #225aa9" />
 </div>
</div>

Analyst Color

$BTC

Bitcoin Could Soar Up To $1M, Says Strike CEO Jack Mallers: 'Violent To The Upside'

Susquehanna analyst Charles Minervino maintains RPC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RES#NYSE">RES</a>) with a Neutral and lowers the price target from $8 to $7.

Susquehanna Maintains Neutral on RPC, Lowers Price Target to $7

Barclays analyst Mathieu Robilliard maintains Iridium Comms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRDM#NASDAQ">IRDM</a>) with a Overweight and raises the price target from $42 to $44.

IRDM

Barclays Maintains Overweight on Iridium Comms, Raises Price Target to $44

Susquehanna analyst Christopher Stathoulopoulos maintains Royal Caribbean Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCL#NYSE">RCL</a>) with a Positive and raises the price target from $150 to $160.

Susquehanna Maintains Positive on Royal Caribbean Gr, Raises Price Target to $160

Rogers shares are trading higher after the company beat Q1 EPS and sales estimates.

Alvotech (ALVO) Q4 2023 Earnings Call Transcript

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Healthequity (HQY – Research Report), Exscientia Plc...

Analysts' Top Healthcare Picks: Healthequity (HQY), Exscientia Plc (EXAI)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Catalent (CTLT – Research Report), Alvotech (ALVO ...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Catalent (CTLT), Alvotech (ALVO) and Immunocore Holdings (IMCR)

AbbVie keeps Humira market share near 100% despite biosimilars: report

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on OptimizeRx (OPRX – Research Report), Alvotech (ALV...

Analysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX), Alvotech (ALVO) and Pacific Biosciences (PACB)

CVS favors Humira copycats hurting AbbVie's market share: Evercore

Alvotech, Teva signs deal to expand access for Humira biosimilar in U.S.

Alvotech/Teva bring new partner to expand access for Humira biosimilar in U.S.

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Alvotech (ALVO – Research Report), Cardinal Health (...